Propensity Score Matching Analysis for Alcohol‐Related Liver Disease
ABSTRACT Objectives This study aims to investigate the impact of comorbidity with chronic hepatitis B (CHB) on the survival rates and incidence of liver cancer in patients with alcohol‐related liver disease (ARLD). Methods Patients with ARLD and those with ARLD co‐morbid with CHB were included in th...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Health Science Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/hsr2.70257 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832583134469685248 |
|---|---|
| author | Fangfang Duan Shanshan Song Hang Zhai Yazhi Wang Jun Cheng Song Yang |
| author_facet | Fangfang Duan Shanshan Song Hang Zhai Yazhi Wang Jun Cheng Song Yang |
| author_sort | Fangfang Duan |
| collection | DOAJ |
| description | ABSTRACT Objectives This study aims to investigate the impact of comorbidity with chronic hepatitis B (CHB) on the survival rates and incidence of liver cancer in patients with alcohol‐related liver disease (ARLD). Methods Patients with ARLD and those with ARLD co‐morbid with CHB were included in this study and designated as the ARLD group and the ARLD + HBV group, respectively. Propensity score matching (PSM) was then employed to compare survival rates and liver cancer development between these two groups. Results Among the 404 patients, 254 were in the ARLD group and 150 in the ARLD + HBV group. After propensity score matching, each group comprised 67 patients. Initially, the ARLD + HBV group exhibited lower 5‐year survival rates compared to the ARLD group (51.3% vs. 70.1%, p < 0.001). However, PSM mitigated this difference, with survival rates now comparable (61.2% vs. 60.9%, p = 0.390). Notably, the ARLD + HBV group showed a higher incidence of liver‐specific mortality after matching (32.6% vs. 6.2%, p = 0.018). Furthermore, although a higher proportion of patients in the ARLD + HBV group developed liver cancer post‐matching, the difference was not statistically significant compared to the ARLD group (15.7% vs. 9.8%, p = 0.170). Conclusion Co‐morbidity with CHB in ARLD patients elevates the risk of liver‐related mortality. |
| format | Article |
| id | doaj-art-055831eba73b4a45aa3a498e8f0c2acc |
| institution | Kabale University |
| issn | 2398-8835 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Health Science Reports |
| spelling | doaj-art-055831eba73b4a45aa3a498e8f0c2acc2025-01-29T03:42:40ZengWileyHealth Science Reports2398-88352025-01-0181n/an/a10.1002/hsr2.70257Propensity Score Matching Analysis for Alcohol‐Related Liver DiseaseFangfang Duan0Shanshan Song1Hang Zhai2Yazhi Wang3Jun Cheng4Song Yang5Division 3, Department of Hepatology Capital Medical University Affiliated Beijing Ditan Hospital Beijing ChinaDivision 3, Department of Hepatology Capital Medical University Affiliated Beijing Ditan Hospital Beijing ChinaDivision 3, Department of Hepatology Capital Medical University Affiliated Beijing Ditan Hospital Beijing ChinaDivision 3, Department of Hepatology Capital Medical University Affiliated Beijing Ditan Hospital Beijing ChinaDivision 3, Department of Hepatology Capital Medical University Affiliated Beijing Ditan Hospital Beijing ChinaDivision 3, Department of Hepatology Capital Medical University Affiliated Beijing Ditan Hospital Beijing ChinaABSTRACT Objectives This study aims to investigate the impact of comorbidity with chronic hepatitis B (CHB) on the survival rates and incidence of liver cancer in patients with alcohol‐related liver disease (ARLD). Methods Patients with ARLD and those with ARLD co‐morbid with CHB were included in this study and designated as the ARLD group and the ARLD + HBV group, respectively. Propensity score matching (PSM) was then employed to compare survival rates and liver cancer development between these two groups. Results Among the 404 patients, 254 were in the ARLD group and 150 in the ARLD + HBV group. After propensity score matching, each group comprised 67 patients. Initially, the ARLD + HBV group exhibited lower 5‐year survival rates compared to the ARLD group (51.3% vs. 70.1%, p < 0.001). However, PSM mitigated this difference, with survival rates now comparable (61.2% vs. 60.9%, p = 0.390). Notably, the ARLD + HBV group showed a higher incidence of liver‐specific mortality after matching (32.6% vs. 6.2%, p = 0.018). Furthermore, although a higher proportion of patients in the ARLD + HBV group developed liver cancer post‐matching, the difference was not statistically significant compared to the ARLD group (15.7% vs. 9.8%, p = 0.170). Conclusion Co‐morbidity with CHB in ARLD patients elevates the risk of liver‐related mortality.https://doi.org/10.1002/hsr2.70257alcohol‐related liver diseasechronic hepatitis Bliver‐specific mortalitypropensity scoring matching |
| spellingShingle | Fangfang Duan Shanshan Song Hang Zhai Yazhi Wang Jun Cheng Song Yang Propensity Score Matching Analysis for Alcohol‐Related Liver Disease Health Science Reports alcohol‐related liver disease chronic hepatitis B liver‐specific mortality propensity scoring matching |
| title | Propensity Score Matching Analysis for Alcohol‐Related Liver Disease |
| title_full | Propensity Score Matching Analysis for Alcohol‐Related Liver Disease |
| title_fullStr | Propensity Score Matching Analysis for Alcohol‐Related Liver Disease |
| title_full_unstemmed | Propensity Score Matching Analysis for Alcohol‐Related Liver Disease |
| title_short | Propensity Score Matching Analysis for Alcohol‐Related Liver Disease |
| title_sort | propensity score matching analysis for alcohol related liver disease |
| topic | alcohol‐related liver disease chronic hepatitis B liver‐specific mortality propensity scoring matching |
| url | https://doi.org/10.1002/hsr2.70257 |
| work_keys_str_mv | AT fangfangduan propensityscorematchinganalysisforalcoholrelatedliverdisease AT shanshansong propensityscorematchinganalysisforalcoholrelatedliverdisease AT hangzhai propensityscorematchinganalysisforalcoholrelatedliverdisease AT yazhiwang propensityscorematchinganalysisforalcoholrelatedliverdisease AT juncheng propensityscorematchinganalysisforalcoholrelatedliverdisease AT songyang propensityscorematchinganalysisforalcoholrelatedliverdisease |